Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Neuropeptides|October 28, 2022
4-hydroxyisoleucine mediated IGF-1/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental ratsSonalika Bhalla, Sidharth Mehan
Journal of Alzheimer'S Disease Reports|August 23, 2019
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical FindingsPallavi Duggal, Sidharth Mehan
Infectious Disorders Drug Targets|December 21, 2020
Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R BlockerTarun Sharma, Sidharth Mehan
Cellular and Molecular Neurobiology|November 18, 2020
Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic GoalsSaloni Rahi, Sidharth Mehan
Metabolic Brain Disease|April 27, 2023
Matrine exerts its neuroprotective effects by modulating multiple neuronal pathwaysSwesha Chhabra, Sidharth Mehan
CNS & Neurological Disorders Drug Targets|June 13, 2019
Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical FindingsKajal Rajdev, Sidharth Mehan
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2021
Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctionsAmbika Shandilya, Sidharth Mehan
Neurochemistry International|May 16, 2021
Targeting PI3K-AKT/mTOR signaling in the prevention of autismAarti Sharma, Sidharth Mehan
Current Drug Discovery Technologies|February 8, 2020
Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical FindingsTarun Kapoor, Sidharth Mehan
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 3, 2023
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathwaysKajal Sherawat, Sidharth Mehan
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Neuropeptides|October 28, 2022
4-hydroxyisoleucine mediated IGF-1/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental ratsSonalika Bhalla, Sidharth Mehan
Journal of Alzheimer'S Disease Reports|August 23, 2019
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical FindingsPallavi Duggal, Sidharth Mehan
Infectious Disorders Drug Targets|December 21, 2020
Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R BlockerTarun Sharma, Sidharth Mehan
Cellular and Molecular Neurobiology|November 18, 2020
Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic GoalsSaloni Rahi, Sidharth Mehan
Metabolic Brain Disease|April 27, 2023
Matrine exerts its neuroprotective effects by modulating multiple neuronal pathwaysSwesha Chhabra, Sidharth Mehan
CNS & Neurological Disorders Drug Targets|June 13, 2019
Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical FindingsKajal Rajdev, Sidharth Mehan
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2021
Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctionsAmbika Shandilya, Sidharth Mehan
Neurochemistry International|May 16, 2021
Targeting PI3K-AKT/mTOR signaling in the prevention of autismAarti Sharma, Sidharth Mehan
Current Drug Discovery Technologies|February 8, 2020
Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical FindingsTarun Kapoor, Sidharth Mehan
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 3, 2023
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathwaysKajal Sherawat, Sidharth Mehan
Pageof 13